VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Monday, December 29, 2025
Stock Comparison
Baidu, Inc. vs Novo Nordisk A/S
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Baidu, Inc.
9888 · The Stock Exchange of Hong Kong Limited
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Baidu, Inc.'s moat claims, evidence, and risks.
View 9888 analysisNovo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisComparison highlights
- Moat score gap: Novo Nordisk A/S leads (85 / 100 vs 71 / 100 for Baidu, Inc.).
- Segment focus: Baidu, Inc. has 4 segments (54.5% in Online Marketing (Search & Feed Ads)); Novo Nordisk A/S has 3 segments (71.1% in Diabetes care).
- Primary market structure: Quasi-Monopoly vs Oligopoly. Pricing power: Moderate vs Moderate.
- Moat breadth: Baidu, Inc. has 10 moat types across 4 domains; Novo Nordisk A/S has 5 across 3.
Primary market context
Baidu, Inc.
Online Marketing (Search & Feed Ads)
Chinese-language search and feed-based online marketing services
Mainland China
Advertisers (SMEs and larger enterprises) buying performance-based and feed ads
Search + feed platform operator / ad marketplace
54.5%
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
Side-by-side metrics
Moat coverage
Shared moat types
Baidu, Inc. strengths
Novo Nordisk A/S strengths
Segment mix
Baidu, Inc. segments
Full profile >Online Marketing (Search & Feed Ads)
Quasi-Monopoly
AI Cloud (IaaS/PaaS/SaaS + GenAI APIs)
Oligopoly
Intelligent Driving & Other Growth Initiatives
Oligopoly
iQIYI (Online Entertainment)
Oligopoly
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.